AMAM

Ambrx Biopharma, Inc. Common Stock
AMAM

Overview Fund Activity
Delisted

AMAM was delisted on the 6th of March, 2024.

Back to rankings

44 hedge funds and large institutions have $568M invested in Ambrx Biopharma, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 17 increasing their positions, 7 reducing their positions, and 13 closing their positions.

Holders
44
Holders Change
+2
Holders Change %
+4.76%
% of All Funds
0.7%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
16
Increased
17
Reduced
7
Closed
13
Calls
$17.6M
Puts
$4.66M
Net Calls
+$12.9M
Net Calls Change
+$12M

Top Buyers

1
Federated Hermes
1
Federated Hermes
Pennsylvania
$27.6M
2
PBA
2
Paradigm Biocapital Advisors
New York
$40.1M
3
CC
3
Commodore Capital
New York
$40.5M
4
CAM
4
Cormorant Asset Management
Massachusetts
$114M
5
GTC
5
Ghost Tree Capital
New York
$6.04M

Top Sellers

1
FCM
1
Farallon Capital Management
California
$0
2
AG
2
Artal Group
Luxembourg
$0
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$0
4
Fidelity Investments
4
Fidelity Investments
Massachusetts
$20.3M
5
Holocene Advisors
5
Holocene Advisors
New York
$5.6M
Name Market Value Shares Shares
Change 		Shares
Change %
DGM
1
Darwin Global Management
Jersey
$192M 16,688,636 – –
CAM
2
Cormorant Asset Management
Massachusetts
$114M 9,923,689 +307,534 +3%
D.E. Shaw & Co
3
D.E. Shaw & Co
New York
$46.1M 4,004,513 -11,395 -0.3%
CC
4
Commodore Capital
New York
$40.5M 3,518,556 +343,556 +11%
PBA
5
Paradigm Biocapital Advisors
New York
$40.1M 3,488,596 +1,838,097 +111%
Federated Hermes
6
Federated Hermes
Pennsylvania
$27.6M 2,395,867 +2,395,867 New
VA
7
VR Adviser
New York
$23.8M 2,070,000 -414,960 -17%
Fidelity Investments
8
Fidelity Investments
Massachusetts
$20.3M 1,761,058 -449,560 -20%
T. Rowe Price Associates
9
T. Rowe Price Associates
Maryland
$9.45M 821,564 -107,753 -12%
Citadel Advisors
10
Citadel Advisors
Florida
$8.84M 768,825 +41,803 +6%
GTC
11
Ghost Tree Capital
New York
$6.04M 525,000 +286,775 +120%
ECM
12
ExodusPoint Capital Management
New York
$5.67M 493,393 +15,835 +3%
Holocene Advisors
13
Holocene Advisors
New York
$5.6M 486,562 -427,192 -47%
Millennium Management
14
Millennium Management
New York
$5.34M 464,633 +178,917 +63%
ABG
15
Ally Bridge Group
New York
$3.23M 281,089 +281,089 New
Macquarie Group
16
Macquarie Group
Australia
$2.88M 250,000 +250,000 New
HS
17
HighVista Strategies
Massachusetts
$2.23M 193,701 +40,270 +26%
NM
18
NWI Management
New York
$1.85M 160,935 +160,935 New
PHP
19
Parkman Healthcare Partners
Connecticut
$1.73M 150,000 +150,000 New
First Manhattan
20
First Manhattan
New York
$1.55M 135,003 – –
LGM
21
Logos Global Management
California
$1.32M 115,000 +115,000 New
TD Asset Management
22
TD Asset Management
Ontario, Canada
$1.27M 110,456 +46,728 +73%
MIM
23
Monashee Investment Management
Massachusetts
$805K 70,000 +70,000 New
Simplex Trading
24
Simplex Trading
Illinois
$788K 68,551 +61,917 +933%
Manulife (Manufacturers Life Insurance)
25
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$682K 59,282 +85 +0.1%
1
2 3